How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill
Huberman Lab Podcast Recap
Published:
Duration: 3 hr 52 min
Guests: Dr. Matthew Hill
Summary
Andrew Huberman and Dr. Matthew Hill discuss the impact of cannabis on health, focusing on its effects on stress, memory, and psychosis. They explore the roles of THC and CBD, endocannabinoid system interactions, and the implications for public health.
What Happened
Cannabis contains over 100 cannabinoids, with THC and CBD being the most prominent. THC is the main psychoactive component, while CBD is non-intoxicating, and the two have different impacts on the brain's cannabinoid receptors. Dr. Matthew Hill explains that THC acts on CB1 receptors, affecting appetite, memory, and perception, while CBD interacts differently, potentially offering therapeutic benefits without intoxication.
Cannabis can alter time perception and stimulate appetite, useful for medical treatments in cancer patients. The endocannabinoid system, involving the CB1 and CB2 receptors, plays a crucial role in maintaining homeostasis in the brain. Cannabis indirectly affects dopamine by acting on inhibitory neurons, which regulate dopamine-producing neurons, unlike other neurotransmitter systems.
The episode highlights the 'entourage effect', where THC, combined with other cannabis compounds, may produce different effects than THC alone. Terpenes in cannabis contribute to its flavor and aroma, with some biological activity. Dr. Hill notes that THC's interaction with CB1 receptors can lead to euphoria, changes in feeding behavior, and potential dissociative states.
Cannabis use is associated with an increased risk of psychosis, particularly with high-potency THC strains. Acute psychotic episodes are rare, but the risk is higher for individuals with a predisposition to schizophrenia or bipolar disorder. Dr. Hill mentions that teenage cannabis use has remained stable post-legalization, but overall use has increased among older adults and women over 55.
The localization of cannabinoid receptors explains why cannabis does not cause fatal overdoses like opiates, as these receptors are sparse in regions controlling cardiac and respiratory functions. Dr. Hill discusses concerns about high-potency cannabis concentrates, which can lead to higher blood THC levels and tolerance.
CBD is shown to be effective in reducing seizures in conditions like Dravet syndrome, with clinical studies using doses much higher than those found in commercial products. Dr. Hill warns that CBD can affect liver enzymes, potentially altering the metabolism of other drugs like THC.
Endocannabinoids like anandamide and 2-arachidonoylglycerol (2-AG) play a role in regulating brain circuits. Anandamide acts as a high-affinity, low-efficacy agonist, while 2-AG has a lower affinity but evokes strong intracellular responses. THC mimics fasting states in the brain, promoting food-seeking behavior by acting on these systems.
Andrew Huberman mentions his upcoming book 'Protocols An Operating Manual for the Human Body', focusing on scientifically substantiated protocols for optimizing health. The book is based on over 30 years of research and is available for pre-sale.
Key Insights
- Cannabis contains over 70 to 100 cannabinoids, with THC and CBD being the most prominent. THC is the main psychoactive component, whereas CBD is non-intoxicating and has potential therapeutic benefits.
- The endocannabinoid system involves CB1 and CB2 receptors, with endocannabinoids like anandamide and 2-AG regulating neurotransmitter release in a retrograde manner. This system maintains homeostasis and affects various brain functions.
- High-potency cannabis products can lead to higher blood THC levels and are associated with increased risks of psychosis, particularly in individuals predisposed to schizophrenia or bipolar disorder.
- CBD's efficacy in reducing seizures is supported by clinical studies using doses much higher than those found in commercial products. It can also affect liver enzymes, potentially altering the metabolism of drugs like THC.